MedTrace Logo

CCC Project - Atrial Fibrillation

NCT02309398 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67028

Last updated 2021-01-27

No results posted yet for this study

Summary

The purpose of this study is to develop and implement quality improvement programs for the treatment of atrial fibrillation (AF) in China based on the successful experience of the AHA-Get with the Guidelines program. This program will use data collection, analysis, feedback, and process improvement to extend the use of evidence-based guidelines throughout the healthcare system and improve patient care of atrial fibrillation.

Conditions

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • Chinese Society of Cardiology

    collaborator OTHER

  • Beijing Institute of Heart, Lung and Blood Vessel Diseases

    lead OTHER

Principal Investigators

  • Dong Zhao, Ph. D · Beijing Institute of Heart, Lung and Blood Vessel Diseases

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02309398 on ClinicalTrials.gov